Augmedics LTD announced that it has received $82.5 million in funding from H.I.G. BioHealth Partners, Revival Healthcare Capital LLC, Almeda Ventures Limited Partnership, Evidity Health Capital, CPMG, Inc. and other investors

Augmedics LTD announced that it has received $82.5 million in a round of funding led by new investor CPMG, Inc. on June 27, 2023. The transaction included participation from new investor Evidity Health Capital, returning investors H.I.G. BioHealth Partners, Revival Healthcare Capital LLC, Almeda Ventures Limited Partnership, and others. The company has raised $148 million funding till date.

Kent McGaughy from CPMG, Inc., and Paul Enever from Evidity Health Capital will join the company's board of directors.